Cargando…

The efficacy of PI3Kγ and EGFR inhibitors on the suppression of the characteristics of cancer stem cells

Cancer stem cells (CSCs) are capable of continuous proliferation, self-renewal and are proposed to play significant roles in oncogenesis, tumor growth, metastasis and cancer recurrence. We have established a model of CSCs that was originally developed from mouse induced pluripotent stem cells (miPSC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Yanning, Afify, Said M., Du, Juan, Liu, Bingbing, Hassan, Ghmkin, Wang, Qing, Li, Hanbo, Liu, Yixin, Fu, Xiaoying, Zhu, Zhengmao, Chen, Ling, Seno, Masaharu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8748513/ https://www.ncbi.nlm.nih.gov/pubmed/35013447 http://dx.doi.org/10.1038/s41598-021-04265-w

Ejemplares similares

Cancer stem cells induced by chronic stimulation with prostaglandin E2 exhibited constitutively activated PI3K axis
por: Minematsu, Hideki, et al.
Publicado: (2022)

Revisiting Cancer Stem Cells as the Origin of Cancer-Associated Cells in the Tumor Microenvironment: A Hypothetical View from the Potential of iPSCs
por: Osman, Amira, et al.
Publicado: (2020)

Metastasis Model of Cancer Stem Cell-Derived Tumors
por: Mansour, Hager, et al.
Publicado: (2020)

Cripto-1 as a Potential Target of Cancer Stem Cells for Immunotherapy
por: Ishii, Hiroko, et al.
Publicado: (2021)

Paclitaxel-Based Chemotherapy Targeting Cancer Stem Cells from Mono- to Combination Therapy
por: Nawara, Hend M., et al.
Publicado: (2021)

Different pancreatic cancer microenvironments convert iPSCs into cancer stem cells exhibiting distinct plasticity with altered gene expression of metabolic pathways
por: Hassan, Ghmkin, et al.
Publicado: (2022)

Differentiation of cancer stem cells into erythroblasts in the presence of CoCl(2)
por: Kumon, Kazuki, et al.
Publicado: (2021)

Blood and Cancer: Cancer Stem Cells as Origin of Hematopoietic Cells in Solid Tumor Microenvironments
por: Hassan, Ghmkin, et al.
Publicado: (2020)

GSK-3α/β and MEK inhibitors assist the microenvironment of tumor initiation
por: Hassan, Ghmkin, et al.
Publicado: (2023)

Paclitaxel and Sorafenib: The Effective Combination of Suppressing the Self-Renewal of Cancer Stem Cells
por: Nawara, Hend M., et al.
Publicado: (2020)

The significance of ErbB2/3 in the conversion of induced pluripotent stem cells into cancer stem cells
por: Hassan, Ghmkin, et al.
Publicado: (2022)

Conversion of Stem Cells to Cancer Stem Cells: Undercurrent of Cancer Initiation
por: Afify, Said M., et al.
Publicado: (2019)

Hypermethylation of DLG3 Promoter Upregulates RAC1 and Activates the PI3K/AKT Signaling Pathway to Promote Breast Cancer Progression
por: Liu, Bingbing, et al.
Publicado: (2021)

Hematopoietic Cells Derived from Cancer Stem Cells Generated from Mouse Induced Pluripotent Stem Cells
por: Hassan, Ghmkin, et al.
Publicado: (2019)

A novel model of liver cancer stem cells developed from induced pluripotent stem cells
por: Afify, Said M., et al.
Publicado: (2020)

Signaling Inhibitors Accelerate the Conversion of mouse iPS Cells into Cancer Stem Cells in the Tumor Microenvironment
por: Du, Juan, et al.
Publicado: (2020)

Metastasis of Cancer Stem Cells Developed in the Microenvironment of Hepatocellular Carcinoma
por: Afify, Said M., et al.
Publicado: (2019)

Exogenous Cripto-1 Suppresses Self-Renewal of Cancer Stem Cell Model
por: Alam, Md Jahangir, et al.
Publicado: (2018)

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway
por: Shao, Jingwei, et al.
Publicado: (2017)

Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ
por: Uehara, Mayuko, et al.
Publicado: (2017)

More Paths to PI3Kγ
por: Stephens, Len, et al.
Publicado: (2013)

[6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling
por: Jiang, Xueyi, et al.
Publicado: (2021)

Novel HSP90-PI3K Dual Inhibitor Suppresses Melanoma Cell Proliferation by Interfering with HSP90-EGFR Interaction and Downstream Signaling Pathways
por: Zhao, Qian, et al.
Publicado: (2020)

Localizing the lipid products of PI3Kγ in neutrophils
por: Norton, Laura, et al.
Publicado: (2016)

Roles of PI3Kγ and PI3Kδ in mantle cell lymphoma proliferation and migration contributing to efficacy of the PI3Kγ/δ inhibitor duvelisib
por: Till, Kathleen J., et al.
Publicado: (2023)

Search for the suppressed decays $B^{+}\rightarrow K^{+}K^{+}\pi^{-}$ and $B^{+}\rightarrow \pi^{+}\pi^{+}K^{-}$
por: Aaij, Roel, et al.
Publicado: (2016)

Fangchinoline exerts antitumour activity by suppressing the EGFR-PI3K/AKT signalling pathway in colon adenocarcinoma
por: Jiang, Fengqi, et al.
Publicado: (2021)

Up-Regulation of PI 3-Kinases and the Activation of PI3K-Akt Signaling Pathway in Cancer Stem-Like Cells Through DNA Hypomethylation Mediated by the Cancer Microenvironment
por: Oo, Aung Ko Ko, et al.
Publicado: (2018)

Targeting EGFR and PI3K pathways in ovarian cancer
por: Glaysher, S, et al.
Publicado: (2013)

LncRNA CANT1 suppresses retinoblastoma progression by repellinghistone methyltransferase in PI3Kγ promoter
por: Ni, Hongyan, et al.
Publicado: (2020)

The role of PI3Kγ in metabolism and macrophage activation
por: Solinas, Giovanni, et al.
Publicado: (2017)

The doubly Cabibbo-suppressed decay $D^{+} \to K^{+}\pi^{-}\pi^{+}$
por: Aitala, E M, et al.
Publicado: (1997)

The Yunnan national medicine Maytenus compound inhibits the proliferation of hepatocellular carcinoma (HCC) by suppressing the activation of the EGFR-PI3K-AKT signaling pathway
por: Zhao, Wen-Tao, et al.
Publicado: (2021)

miRs-134 and -370 function as tumor suppressors in colorectal cancer by independently suppressing EGFR and PI3K signalling
por: El-Daly, Sherien M., et al.
Publicado: (2016)

Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
por: Chang, Kwang-Yu, et al.
Publicado: (2013)

SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals
por: She, Kelin, et al.
Publicado: (2019)

Function, Regulation and Biological Roles of PI3Kγ Variants
por: Nürnberg, Bernd, et al.
Publicado: (2019)

JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation
por: Zhang, Bo, et al.
Publicado: (2021)

Observation of the suppressed ADS modes $B^\pm \to [\pi^\pm K^\mp \pi^+\pi^-]_D K^\pm$ and $B^\pm \to [\pi^\pm K^\mp \pi^+\pi^-]_D \pi^\pm$
por: Aaij, R, et al.
Publicado: (2013)

Baicalin suppresses glaucoma pathogenesis by regulating the PI3K/AKT signaling in vitro and in vivo
por: Zhao, Ningmin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ethmbu44ukajtek1ojj7l4ir3v